Ernexa Therapeutics Inc. ( ERNA) - Key Metrics
ERNA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$3.39 | -$3.51 | -$3.51 |
| 2026Q1 | $0 | -$6.95 | -$2.86 | -$2.86 |
| 2025Q4 | $0 | -$4.78 | -$3.65 | -$3.70 |
| 2025Q3 | $0 | -$3.77 | -$3.87 | -$3.93 |
| 2025Q2 | $0 | -$15.15 | -$12.22 | -$12.22 |
ERNA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.49 |
| 2026Q1 | 0% | -0.18 |
| 2025Q4 | 0% | -1.58 |
| 2025Q3 | 0% | -1.83 |
| 2025Q2 | 0% | -0.75 |
ERNA
Price: $4.86
52 week price:
Earnings Per Share: -0.41 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 5.0 million